CM
Caption Management Portfolio holdings
AUM
$1.09B
This Quarter Return
+0.55%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$567M
AUM Growth
+$567M
(+21%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
18.3%
Top 10 Holdings %
Top 10 Hldgs %
26.11%
Holding
868
New
165
Increased
70
Reduced
65
Closed
152
Top Buys
| 1 |
Lockheed Martin
LMT
|
$14.3M |
| 2 |
argenx
ARGX
|
$13.3M |
| 3 |
Compañía de Minas Buenaventura
BVN
|
$13M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$11.8M |
| 5 |
Option Care Health
OPCH
|
$10.9M |
Top Sells
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
$16.7M |
| 2 |
Sabre
SABR
|
$11M |
| 3 |
Walt Disney
DIS
|
$10.5M |
| 4 |
UBS Group
UBS
|
$10.2M |
| 5 |
CBL
CBL Properties
CBL
|
$8.59M |
Sector Composition
| 1 | Healthcare | 25.5% |
| 2 | Technology | 18.79% |
| 3 | Consumer Discretionary | 8.99% |
| 4 | Communication Services | 8.65% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSVT
851
DELISTED
2seventy bio
TSVT
| – | – |
0
| – | – |
|
852
Xerox
XRX
$478M
| – | – |
0
| – | – |
|
853
Nu Holdings
NU
$72B
| – | – |
0
| – | – |
|
854
Nuvalent
NUVL
$5.74B
| – | – |
0
| – | – |
|
855
Novo Nordisk
NVO
$252B
| – | – |
0
| – | – |
|
856
Regenxbio
RGNX
$498M
| – | – |
-5,804
| Closed | -$110K |
|
857
JFrog
FROG
$5.58B
| – | – |
0
| – | – |
|
858
Griffon
GFF
$3.58B
| – | – |
-12,100
| Closed | -$387K |
|
859
MarineMax
HZO
$538M
| – | – |
0
| – | – |
|
860
Targa Resources
TRGP
$35.2B
| – | – |
0
| – | – |
|
|
DO
861
DELISTED
Diamond Offshore Drilling, Inc.
DO
| – | – |
0
| – | – |
|
|
MORF
862
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
0
| – | – |
|
|
LL
863
DELISTED
LL Flooring Holdings, Inc.
LL
| – | – |
0
| – | – |
|
|
CERE
864
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| – | – |
0
| – | – |
|
|
ERF
865
DELISTED
Enerplus Corporation
ERF
| – | – |
-85,000
| Closed | -$1.22M |
|
866
Ares Capital
ARCC
$15.7B
| – | – |
0
| – | – |
|
867
Arcturus Therapeutics
ARCT
$467M
| – | – |
0
| – | – |
|
868
Ares Management
ARES
$38.8B
| – | – |
0
| – | – |
|